38
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Contribution of neuroblastoma-derived exosomes to the production of pro-tumorigenic signals by bone marrow mesenchymal stromal cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          The bone marrow (BM) niche is a microenvironment promoting survival, dormancy and therapeutic resistance in tumor cells. Central to this function are mesenchymal stromal cells (MSCs). Here, using neuroblastoma (NB) as a model, we demonstrate that NB cells release an extracellular vesicle (EVs) whose protein cargo is enriched in exosomal proteins but lacks cytokines and chemokines. Using three different purification methods, we then demonstrate that NB-derived exosomes were captured by MSCs and induced the production of pro-tumorigenic cytokines and chemokines, including interleukin-6 (IL-6), IL-8/CXCL8, vascular endothelial cell growth factor and monocyte-chemotactic protein-1, with exosomes prepared by size exclusion chromatography having the highest activity. We found no correlation between the IL-6 and IL-8/CXCL8 stimulatory activity of exosomes from eight NB cell lines and their origin, degree of MYCN amplification, drug resistance and disease status. We then demonstrate that the uptake of NB exosomes by MSCs was associated with a rapid increase in ERK1/2 and AKT activation, and that blocking ERK1/2 but not AKT activation inhibited the IL-6 and IL-8/CXCL8 production by MSCs without affecting exosome uptake. Thus, we describe a new mechanism by which NB cells induce in MSCs an inflammatory reaction that contributes to a favorable microenvironment in the BM.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: not found
          • Article: not found

          Recent advances in neuroblastoma.

          John Maris (2010)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            FunRich: An open access standalone functional enrichment and interaction network analysis tool.

            As high-throughput techniques including proteomics become more accessible to individual laboratories, there is an urgent need for a user-friendly bioinformatics analysis system. Here, we describe FunRich, an open access, standalone functional enrichment and network analysis tool. FunRich is designed to be used by biologists with minimal or no support from computational and database experts. Using FunRich, users can perform functional enrichment analysis on background databases that are integrated from heterogeneous genomic and proteomic resources (>1.5 million annotations). Besides default human specific FunRich database, users can download data from the UniProt database, which currently supports 20 different taxonomies against which enrichment analysis can be performed. Moreover, the users can build their own custom databases and perform the enrichment analysis irrespective of organism. In addition to proteomics datasets, the custom database allows for the tool to be used for genomics, lipidomics and metabolomics datasets. Thus, FunRich allows for complete database customization and thereby permits for the tool to be exploited as a skeleton for enrichment analysis irrespective of the data type or organism used. FunRich (http://www.funrich.org) is user-friendly and provides graphical representation (Venn, pie charts, bar graphs, column, heatmap and doughnuts) of the data with customizable font, scale and color (publication quality).
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

              Mesenchymal stem cells or multipotent stromal cells (MSCs) isolated from the bone marrow of adult organisms were initially characterized as plastic adherent, fibroblastoid cells with the capacity to generate heterotopic osseous tissue when transplanted in vivo. In recent years, MSCs or MSC-like cells have been shown to reside within the connective tissue of most organs, and their surface phenotype has been well described. A large number of reports have also indicated that the cells possess the capacity to transdifferentiate into epithelial cells and lineages derived from the neuroectoderm. The broad developmental plasticity of MSCs was originally thought to contribute to their demonstrated efficacy in a wide variety of experimental animal models of disease as well as in human clinical trials. However, new findings suggest that the ability of MSCs to alter the tissue microenvironment via secretion of soluble factors may contribute more significantly than their capacity for transdifferentiation in tissue repair. Herein, we critically evaluate the literature describing the plasticity of MSCs and offer insight into how the molecular and functional heterogeneity of this cell population, which reflects the complexity of marrow stroma as an organ system, may confound interpretation of their transdifferentiation potential. Additionally, we argue that this heterogeneity also provides a basis for the broad therapeutic efficacy of MSCs.
                Bookmark

                Author and article information

                Journal
                J Extracell Vesicles
                J Extracell Vesicles
                ZJEV
                zjev20
                Journal of Extracellular Vesicles
                Taylor & Francis
                2001-3078
                2017
                25 June 2017
                : 6
                : 1
                : 1332941
                Affiliations
                [ a ] The Saban Research Institute of Children’s Hospital Los Angeles, University of Southern California , Los Angeles, CA, USA
                [ b ] Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Southern California , Los Angeles, CA, USA
                [ c ] Department of Pediatrics, University of Southern California , Los Angeles, CA, USA
                [ d ] Department of Pathology and Laboratory Medicine, University of Southern California , Los Angeles, CA, USA
                [ e ] Department of Molecular Microbiology and Immunology, University of Southern California , Los Angeles, CA, USA
                [ f ] Department of Biochemistry and Molecular Biology, Keck School of Medicine, University of Southern California , Los Angeles, CA, USA
                [ g ] Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068-CNRS UMR7258, Aix-Marseille Université, Institut Paoli-Calmettes , Marseille, France
                Author notes
                CONTACT Yves A. DeClerck declerck@ 123456usc.edu Children’s Hospital Los Angeles , 4650 Sunset Boulevard, MS#54, Los Angeles, CA 90027, USA
                Author information
                http://orcid.org/0000-0003-2981-4182
                http://orcid.org/0000-0002-5481-6780
                http://orcid.org/0000-0001-8768-1790
                http://orcid.org/0000-0002-3688-0113
                Article
                1332941
                10.1080/20013078.2017.1332941
                5505006
                28717423
                5cc7efa5-4d10-40a6-9f7f-0045f1bf453f
                © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 10 March 2017
                Page count
                Figures: 9, References: 69, Pages: 16
                Funding
                Funded by: Institut National du Cancer 10.13039/501100006364
                Award ID: subvention 2013-105
                Funded by: National Cancer Institute 10.13039/100000054
                Award ID: P)1 CA81403
                Funded by: National Cancer Institute 10.13039/100000054
                Award ID: U54CA163117
                Funded by: Fund for Scientifc Research
                Award ID: FWO G.0846.15
                Funded by: French Foundation for Cancer Research
                Award ID: PJA 20161204584
                Funded by: National Research Agency
                Award ID: ANR-11-IDEX-0001-02
                Funded by: St. Baldrick’s Foundation 10.13039/100006058
                Award ID: 430044
                This work was supported by grants P01 CA81403 and U54 CA163117 (to YAD) from the National Institutes of Health, and a grant (to YAD) from the St. Baldrick’s foundation. The work in PZ laboratory was supported by the French Foundation for Cancer Research (ARC, PJA 20161204584), Institut National du Cancer (INCa, subvention 2013-105) and National Research Agency (ANR, Investissements d’Avenir, A*MIDEX project ANR-11-IDEX-0001-02), and by the Research Foundation – Flanders (FWO G.0846.15).
                Categories
                Research Article
                Research Article

                exosomes,mesenchymal stromal cells,cell–cell interaction,extracellular vesicles,extracellular-signal-regulated kinase,neuroblastoma

                Comments

                Comment on this article